Singapore's Temasek has a sticky China problem
The author is a Reuters Breakingviews columnist. The opinions expressed are his own. Updates to add graphics.
By Anshuman Daga
SINGAPORE, July 10 (Reuters Breakingviews) -There's no hiding for Temasek. The Singapore sovereign investor's portfolio value edged up 1.8% to S$389 billion ($288 billion) in the year to March. That's after dipping in the prior year, but the group's heavy focus on China is a drag. For CEO Dilhan Pillay, it is tricky to pull back from the world's second-largest economy to shore up returns.
Like other global investors, the geographic split of Temasek's assets is changing fast. Its exposure to the Americas at 22% of its portfolio by underlying assets overtook China for the first time in a decade to be second only to Singapore. The share of the People's Republic fell to 19%, 3 percentage points lower than in 2022, but Temasek remains one of the largest institutional investors in the country. By contrast, China accounts for less than 3% of the MSCI All Country World Index .MIWD00000PUS.
A good chunk of Temasek's China exposure is stuck in private investments.Ant is one of them.The Jack Ma-founded fintech giant is worth perhaps a quarter of the $315 billion valuation it flaunted before it tried and failed to float in 2020. Another is a decade-old minority stake in health and beauty company A.S. Watson Group, a unit majority-owned by CK Hutchison 0001.HK. Temasek's subsidiary, PSA, also owns a multi-billion-dollar 20% stake in the Hong Kong-based conglomerate's ports business and has struggled to offload it.
Temasek's public stakes in the country include out-of-vogue tech companies Tencent 0700.HK and Alibaba 9988.HK. And while its holdings in banks such as Industrial and Commercial Bank of China 601398.SS have fared well of late, the state-backed lender is among those bearing the brunt of the country's debt worries. Temasek's Deputy CEO Chia Song Hwee told Breakingviews that "reshaping" the large China portfolio, including focusing on faster-growth sectors, would take time.
Awkwardly, that task is further complicated by Singapore's close financial relationship with its large Asian neighbour. Were Temasek to pare its exposure to China as much as many U.S. funds have done, it would risk a backlash from Beijing. Many in Singapore still believe in China's prospects beyond the short term, and sovereign investors are known for taking a long view. Temasek's hands, though, appear somewhat tied.
Follow @anshumandaga on X
CONTEXT NEWS
Singapore state investor Temasek on July 9 reported a net portfolio value of S$389 billion ($288 billion) for the financial year to the end of March, a 1.8% increase from the previous year.
($1 = 1.3507 Singapore dollars)
Temasek's portfolio value is rising again Temasek's portfolio value is rising again https://www.reuters.com/graphics/BRV-BRV/zjvqynoejvx/chart.png
Temasek's China portfolio holdings decline Temasek's China portfolio holdings decline https://www.reuters.com/graphics/BRV-BRV/gdvzmkbwjpw/chart.png
Editing by Una Galani and Aditya Srivastav
Mga Kaugnay na Asset
Pinakabagong Balita
Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.
Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.
Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.
